Login / Signup

The Association Between Service Connection and Treatment Outcome in Veterans Undergoing Residential PTSD Treatment.

Jessica L RodriguezAndrew C HaleHolloway N MarstonChelsea E Sage-GermainTheodore P WrightScott A DriesengaShannon M MartinRebecca K Sripada
Published in: The Psychiatric quarterly (2021)
The Department of Veterans Affairs has invested significant time and resources into the treatment of posttraumatic stress disorder (PTSD). Despite concerted efforts, a significant portion of patients do not respond optimally to trauma-focused treatment. One of the factors that has been hypothesized to be associated with treatment response is participation in the Veterans Benefits Administration service-connected disability process. This factor may be particularly relevant in the residential treatment setting, where most participants are engaged in the compensation seeking process. We conducted a retrospective chart review of 105 veterans who completed Cognitive Processing Therapy (CPT) in a residential rehabilitation program. ANCOVAs that adjusted for baseline PTSD severity compared symptom change between those who were and were non-compensation seeking at the time of treatment. Compensation seeking status was associated with significantly less symptom improvement over the course of CPT after adjusting for baseline PTSD severity (F(1, 102) = 4.29, p < .001, η2 = .03). Sensitivity analyses did not detect a similar effect during a prior coping skills phase of treatment. During CPT, clinically significant change was met by 66.7% of non-compensation seeking veterans (M = -15, SD = 14.56) and by 40.1% of the compensation seeking group (M = -7.1, SD = 12.24). Compensation-seeking may be associated with reduced response to trauma-focused treatment in certain settings. Future research is needed to better understand the mechanisms underlying this effect.
Keyphrases
  • mental health
  • posttraumatic stress disorder
  • healthcare
  • depressive symptoms
  • social support
  • multiple sclerosis
  • air pollution
  • tyrosine kinase
  • prognostic factors
  • replacement therapy
  • patient reported outcomes